Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» V114
V114
Merck snags priority review for Prevnar 13 rival — just one month after Pfizer sent its follow-on to the FDA
Merck snags priority review for Prevnar 13 rival — just one month after Pfizer sent its follow-on to the FDA
Endpoints
Merck
V114
pneumococcal disease
vaccines
FDA
priority review
Prevnar 13
Pfizer
Flag link:
Merck's rival to Pfizer's Prevnar 13 hits goal in phase 3 again
Merck's rival to Pfizer's Prevnar 13 hits goal in phase 3 again
Fierce Biotech
Merck
Pfizer
vaccines
Prevnar 13
clinical trials
V114
pneumococcal disease
Flag link:
Merck’s pneumonia vaccine posts two more hits
Merck’s pneumonia vaccine posts two more hits
EP Vantage
Merck
vaccines
V114
Pfizer
Prevnar 13
Flag link:
Merck’s Experimental Pneumonia Vaccine Hits the Mark in Two Phase III Studies
Merck’s Experimental Pneumonia Vaccine Hits the Mark in Two Phase III Studies
BioSpace
Merck
vaccines
V114
clinical trials
HIV
pneumonia
pneumococcal disease
Flag link:
Looking to topple Pfizer's Prevnar 13 dynasty, Merck claims another win for its 'breakthrough' pneumococcal conjugate vaccine
Looking to topple Pfizer's Prevnar 13 dynasty, Merck claims another win for its 'breakthrough' pneumococcal conjugate vaccine
Endpoints
Merck
Pfizer
vaccines
pneumococcal disease
V114
Prevnar 13
FDA
Flag link:
FDA blesses Merck’s PhIII effort to topple a mega-blockbuster — but there’s also a little biotech in this game
FDA blesses Merck’s PhIII effort to topple a mega-blockbuster — but there’s also a little biotech in this game
Endpoints
Merck
V114
vaccines
FDA
breakthrough status
Prevnar 13
Pfizer
Flag link:
Merck pits its pneumococcal shot against Pfizer's mammoth Prevnar in head-to-head ph3
Merck pits its pneumococcal shot against Pfizer's mammoth Prevnar in head-to-head ph3
Fierce Pharma
Merck
pneumococcal disease
V114
Pfizer
Prevnar 13
Flag link:
Merck CEO: Gardasil plus pipeline equals big things ahead for vaccines
Merck CEO: Gardasil plus pipeline equals big things ahead for vaccines
Fierce Pharma
Merck
Pharma CEOs
Ken Frazier
vaccines
Gardasil
V114
Moderna Therapeutics
Flag link: